Interferon-γ down-regulates expression of tumor necrosis factor-α converting enzyme/a disintegrin and metalloproteinase 17 in activated hepatic stellate cells of rats

International Journal of Molecular Medicine

Volumn 17, Issue 4, 2006, Pages 605-616

  Fujita, Tomohiro ^a   Maesawa, Chihaya ^a   Oikawa, Kanta ^a   Nitta, Hiroyuki ^a   Wakabayashi, Go ^a   Masuda, Tomoyuki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

ADAM17; Hepatic stellate cells; Interferon ; Proteome; Tumor necrosis factor

Indexed keywords

ACTIN; ADAM PROTEIN; FGFR1 PROTEIN, RAT; FIBROBLAST GROWTH FACTOR RECEPTOR 1; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; RECOMBINANT GAMMA INTERFERON; SCATTER FACTOR; TGFB1 PROTEIN, RAT; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ANIMAL; ARTICLE; CELL CULTURE; CHEMISTRY; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION; GENETICS; LIVER; METABOLISM; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING; WISTAR RAT;

ACTINS; ADAM PROTEINS; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION; HEPATOCYTE GROWTH FACTOR; INTERFERON-GAMMA, RECOMBINANT; LIVER; MUSCLE, SMOOTH; RATS; RATS, WISTAR; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33746696162     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.17.4.605     Document Type: Article

References (56)

1. Milani S, Herbst H, Schuppan D, Hahn EG and Stein H: In situ hybridization for procollagen types I, III and IV mRNA in normal and fibrotic rat liver: evidence for predominant expression in nonparenchymal liver cells. Hepatology 10: 84-92, 1989.
2. Friedman SL: Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 328: 1828-1835, 1993.
3. Yokoi Y, Namihisa T, Kuroda H, et al: Immunocytochemical detection of desmin in fat-storing cells (Ito cells). Hepatology 4: 709-714, 1984.
4. Pinzani M, Gesualdo L, Sabbah GM and Abboud HE: Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest 84: 1786-1793, 1989.
5. Ramadori G, Veit T, Schwogler S, et al: Expression of the gene of the alpha-smooth muscle-actin isoform in rat liver and in rat fat-storing (ITO) cells. Virchows Arch B Cell Pathol Incl Mol Pathol 59: 349-357, 1990.
6. Hendriks HF, Verhoofstad WA, Brouwer A, De Leeuw AM and Knook DL: Perisinusoidal fat-storing cells are the main vitamin A storage sites in rat liver. Exp Cell Res 160: 138-149, 1985. (Pubitemid 16227414)
7. Blomhoff R and Wake K: Perisinusoidal stellate cells of the liver: important roles in retinol metabolism and fibrosis. FASEB J 5: 271-277, 1991. (Pubitemid 21892886)
8. Friedman SL, Rockey DC, McGuire RF, Maher JJ, Boyles JK and Yamasaki G: Isolated hepatic lipocytes and Kupffer cells from normal human liver: morphological and functional characteristics in primary culture. Hepatology 15: 234-243, 1992.
9. Rockey DC, Boyles JK, Gabbiani G and Friedman SL: Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol 24: 193-203, 1992.
10. Burt AD, Le Bail B, Balabaud C and Bioulac-Sage P: Morphologic investigation of sinusoidal cells. Semin Liver Dis 13: 21-38, 1993.
11. Seyer JM, Hutcheson ET and Kang AH: Collagen polymorphism in normal and cirrhotic human liver. J Clin Invest 59: 241-248, 1977.
12. Kent G, Gay S, Inouye T, Bahu R, Minick OT and Popper H: Vitamin A-containing lipocytes and formation of type III collagen in liver injury. Proc Natl Acad Sci USA 73: 3719-3722, 1976.
13. Scharffetter K, Heckmann M, Hatamochi A, et al: Synergistic effect of tumor necrosis factor-alpha and interferon-gamma on collagen synthesis of human skin fibroblasts in vitro. Exp Cell Res 181: 409-419, 1989.
14. Jimenez SA, Freundlich B and Rosenbloom J: Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J Clin Invest 74: 1112-1116, 1984. (Pubitemid 14031053)
15. Rosenbloom J, Feldman G, Freundlich B and Jimenez SA: Transcriptional control of human diploid fibroblast collagen synthesis by gamma-interferon. Biochem Biophys Res Commun 123: 365-372, 1984. (Pubitemid 14030145)
16. Duncan MR and Berman B: Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation. J Exp Med 162: 516-527, 1985.
17. Goldring MB, Sandell LJ, Stephenson ML and Krane SM: Immune interferon suppresses levels of procollagen mRNA and type II collagen synthesis in cultured human articular and costal chondrocytes. J Biol Chem 261: 9049-9055, 1986.
18. Smith DD, Gowen M and Mundy GR: Effects of interferon-gamma and other cytokines on collagen synthesis in fetal rat bone cultures. Endocrinology 120: 2494-2499, 1987.
19. Tsuruoka N, Sugiyama M, Tawaragi Y, et al: Inhibition of in vitro angiogenesis by lymphotoxin and interferon-gamma. Biochem Biophys Res Commun 155: 429-435, 1988.
20. Granstein RD, Deak MR, Jacques SL, et al: The systemic administration of gamma interferon inhibits collagen synthesis and acute inflammation in a murine skin wounding model. J Invest Dermatol 93: 18-27, 1989.
21. Shen H, Zhang M, Minuk GY and Gong Y: Different effects of rat interferon alpha, beta and gamma on rat hepatic stellate cell proliferation and activation. BMC Cell Biol 3: 9, 2002.
22. Vaillant B, Chiaramonte MG, Cheever AW, Soloway PD and Wynn TA: Regulation of hepatic fibrosis and extracellular matrix genes by the th response: new insight into the role of tissue inhibitors of matrix metalloproteinases. J Immunol 167: 7017-7026, 2001.
23. Senoo H: Structure and function of hepatic stellate cells. Med Electron Microsc 37: 3-15, 2004. (Pubitemid 38514675)
24. Rockey DC, Maher JJ, Jarnagin WR, Gabbiani G and Friedman SL: Inhibition of rat hepatic lipocyte activation in culture by interferon-gamma. Hepatology 16: 776-784, 1992.
25. Rosenfeld J, Capdevielle J, Guillemot JC and Ferrara P: In-gel digestion of proteins for internal sequence analysis after oneor two-dimensional gel electrophoresis. Anal Biochem 203: 173-179, 1992.
26. Katayama H, Nagasu T and Oda Y: Improvement of in-gel digestion protocol for peptide mass fingerprinting by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 15: 1416-1421, 2001. (Pubitemid 32786408)
27. Aarskog NK and Vedeler CA: Real-time quantitative polymerase chain reaction. A new method that detects both the peripheral myelin protein 22 duplication in Charcot-Marie-Tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liability to pressure palsies. Hum Genet 107: 494-498, 2000.
28. Marra F: Chemokines in liver inflammation and fibrosis. Front Biosci 7: 1899-1914, 2002.
29. Bataller R and Brenner DA: Liver fibrosis. J Clin Invest 115: 209-218, 2005.
30. Platanias LC: Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5: 375-386, 2005.
31. Black RA, Rauch CT, Kozlosky CJ, et al: A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385: 729-733, 1997.
32. Moss ML, Jin SL, Milla ME, et al: Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385: 733-736, 1997.
33. Peschon JJ, Slack JL, Reddy P, et al: An essential role for ectodomain shedding in mammalian development. Science 282: 1281-1284, 1998.
34. Sunnarborg SW, Hinkle CL, Stevenson M, et al: Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J Biol Chem 277: 12838-12845, 2002. (Pubitemid 34952648)
35. Montero JC, Yuste L, Diaz-Rodriguez E, Esparis-Ogando A and Pandiella A: Differential shedding of transmembrane neuregulin isoforms by the tumor necrosis factor-alpha-converting enzyme. Mol Cell Neurosci 16: 631-648, 2000.
36. Diaz-Rodriguez E, Montero JC, Esparis-Ogando A, Yuste L and Pandiella A: Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding. Mol Biol Cell 13: 2031-2044, 2002.
37. Zhang Y, Jiang J, Black RA, Baumann G and Frank SJ: Tumor necrosis factor-alpha converting enzyme (TACE) is a growth hormone binding protein (GHBP) sheddase: the metalloprotease TACE/ADAM-17 is critical for (PMA-induced) GH receptor proteolysis and GHBP generation. Endocrinology 141: 4342-4348, 2000.
38. Mifune M, Ohtsu H, Suzuki H, et al: G protein coupling and second messenger generation are indispensable for metalloprotease-dependent, heparin-binding epidermal growth factor shedding through angiotensin II type-1 receptor. J Biol Chem 280: 26592-26599, 2005.
39. Lautrette A, Li S, Alili R, et al: Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach. Nat Med 11: 867-874, 2005. (Pubitemid 41161119)
40. Paizis G, Cooper ME, Schembri JM, Tikellis C, Burrell LM and Angus PW: Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver. Gastroenterology 123: 1667-1676, 2002.
41. Bataller R, Sancho-Bru P, Gines P, et al: Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. Gastroenterology 125: 117-125, 2003.
42. Bataller R, Schwabe RF, Choi YH, et al: NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 112: 1383-1394, 2003.
43. Bataller R, Gines P, Nicolas JM, et al: Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 118: 1149-1156, 2000.
44. Bataller R, Gabele E, Schoonhoven R, et al: Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver. Am J Physiol Gastrointest Liver Physiol 285: G642-G651, 2003.
45. Kanno K, Tazuma S and Chayama K: AT1A-deficient mice show less severe progression of liver fibrosis induced by CCl(4). Biochem Biophys Res Commun 308: 177-183, 2003.
46. Jonsson JR, Clouston AD, Ando Y, et al: Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology 121: 148-155, 2001.
47. Paizis G, Gilbert RE, Cooper ME, et al: Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis. J Hepatol 35: 376-385, 2001.
48. Ramalho LN, Ramalho FS, Zucoloto S, et al: Effect of losartan, an angiotensin II antagonist, on secondary biliary cirrhosis. Hepatogastroenterology 49: 1499-1502, 2002.
49. Wei HS, Lu HM, Li DG, et al: The regulatory role of AT 1 receptor on activated HSCs in hepatic fibrogenesis: effects of RAS inhibitors on hepatic fibrosis induced by CCl(4). World J Gastroenterol 6: 824-828, 2000.
50. Wei HS, Li DG, Lu HM, et al: Effects of AT1 receptor antagonist, losartan, on rat hepatic fibrosis induced by CCl(4). World J Gastroenterol 6: 540-545, 2000.
51. Tuncer I, Ozbek H, Ugras S and Bayram I: Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat. The effect of AT1-R blocker on the hepatic fibrosis. Exp Toxicol Pathol 55: 159-166, 2003.
52. Reddy P, Slack JL, Davis R, et al: Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. J Biol Chem 275: 14608-14614, 2000.
53. Althoff K, Reddy P, Voltz N, Rose-John S and Mullberg J: Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins. Eur J Biochem 267: 2624-2631, 2000.
54. Hellemans K, Michalik L, Dittie A, et al: Peroxisome proliferator- activated receptor-beta signaling contributes to enhanced proliferation of hepatic stellate cells. Gastroenterology 124: 184-201, 2003.
55. Waite KJ, Floyd ZE, Arbour-Reily P and Stephens JM: Interferon-gamma- induced regulation of peroxisome proliferator-activated receptor gamma and STATs in adipocytes. J Biol Chem 276: 7062-7068, 2001.
56. Weng HL, Wang BE, Jia JD, et al: Effect of interferon-gamma on hepatic fibrosis in chronic hepatitis B virus infection: a randomized controlled study. Clin Gastroenterol Hepatol 3: 819-828, 2005.